Philadelphia positive acute lymphocytic leukaemia is a challenging form of blood cancer that affects adults more commonly than children. Modern treatments have dramatically improved outcomes for patients, but the disease still requires careful management and close monitoring throughout the treatment journey.
Understanding the Disease and How Common It Is
Philadelphia positive acute lymphocytic leukaemia, often shortened to Ph+ ALL, is a specific type of blood cancer that begins in the bone marrow, which is the soft inner part of bones where blood cells are made. This condition affects white blood cells called lymphocytes, which normally help the body fight infections. In Ph+ ALL, these cells become abnormal and multiply too quickly, crowding out healthy blood cells and spreading throughout the body.[1]
The condition gets its name from the Philadelphia chromosome, an unusual genetic change that scientists can spot when they examine the cancer cells under a microscope. This abnormality appears in about 20 to 30 out of every 100 adults who are diagnosed with acute lymphocytic leukaemia, making it the most common genetic abnormality in adult ALL.[1][2] What makes this particularly important is that the frequency of Ph+ ALL increases dramatically as people get older. While it can affect anyone, it becomes much more common in individuals aged 50 and above, occurring in up to half of all ALL cases diagnosed in this age group.[1]
The disease is relatively rare when looking at the broader picture of all cancers. Acute lymphocytic leukaemia itself makes up less than one out of every 100 cancers diagnosed in the United States, and Ph+ ALL represents just a portion of those cases.[4] Although it most commonly affects children between ages 2 and 5 when considering ALL as a whole, the Philadelphia positive subtype specifically is more frequently seen in adult patients.[3]
What Causes Philadelphia Positive Acute Lymphocytic Leukaemia
The root cause of Ph+ ALL lies in a specific genetic change that happens inside cells. This change involves two chromosomes in the body—chromosome 9 and chromosome 22. In healthy cells, these chromosomes stay separate and perform their normal functions. However, in Ph+ ALL, a piece of chromosome 9 breaks off and attaches itself to chromosome 22, and vice versa. This swap creates what scientists call a translocation, specifically labeled as t(9;22).[4]
When this translocation occurs, two genes that normally live on separate chromosomes—the ABL1 gene on chromosome 9 and the BCR gene on chromosome 22—end up joining together. This creates a new, abnormal gene called BCR-ABL1. The problem with this fusion gene is that it produces a protein called tyrosine kinase that never switches off. Normally, tyrosine kinase helps control cell growth, turning on and off as needed. But the BCR-ABL1 version keeps sending signals for cells to grow and multiply without stopping, like a gas pedal stuck to the floor.[1][3]
This constant signal leads to the uncontrolled growth of immature white blood cells, called blast cells or lymphoblasts. These abnormal cells build up in the bone marrow where blood is made, leaving less room for healthy red blood cells, white blood cells, and platelets to develop. Eventually, these blast cells spill out into the bloodstream and can travel to other parts of the body, including the lymph nodes, liver, spleen, brain, and spinal cord.[3]
Scientists are still investigating exactly why these genetic changes happen in the first place. In young children with ALL, some of these gene changes may have occurred before birth. In adults, exposure to certain substances that can damage DNA, such as tobacco, has been linked to the development of acute lymphocytic leukaemia.[4]
Risk Factors That Increase Your Chances
Several factors can increase a person’s likelihood of developing Philadelphia positive acute lymphocytic leukaemia. Age stands out as one of the most significant risk factors. The condition becomes more common as people grow older, with the highest risk occurring in adults over 50 years of age. This age-related increase happens partly because chromosomal abnormalities like the Philadelphia chromosome become more likely to develop as the body ages.[1]
Certain inherited genetic conditions also raise the risk. People born with disorders such as Down syndrome or Fanconi anaemia have a higher chance of developing ALL, including the Philadelphia positive type. These conditions affect how cells grow and divide, making genetic mutations more likely to occur.[4]
Exposure to radiation, particularly during development before birth or from previous radiation therapy for other cancers, can increase risk. The Epstein-Barr virus and human T-cell leukaemia virus have also been associated with a higher risk of developing acute lymphocytic leukaemia.[4] Environmental factors and lifestyle choices, including tobacco use, may contribute to the development of the disease in adults.[4]
There are also some patterns related to race and sex. People who are white have a slightly higher risk of developing ALL compared to other racial groups. When it comes to sex differences, the pattern changes with age. In infants under one year old, girls face a higher risk than boys. However, after age one, males have a higher risk of developing the disease.[4]
Recognising the Symptoms
The symptoms of Philadelphia positive acute lymphocytic leukaemia typically develop quickly over a period of days or weeks. This rapid onset happens because the word “acute” in the disease name means it progresses fast, unlike chronic forms of leukaemia that develop slowly over time.[3] The symptoms arise because the excessive number of abnormal blast cells in the bone marrow leaves insufficient space for healthy blood cells to develop properly.
One of the most common symptoms is persistent fatigue that doesn’t improve with rest. This tiredness occurs because the body doesn’t have enough healthy red blood cells to carry oxygen to tissues and muscles. People may also notice they look paler than usual, as the shortage of red blood cells affects skin colour.[4]
Bleeding and bruising happen more easily than normal because the disease reduces the number of platelets, the blood cells responsible for clotting. People might experience frequent nosebleeds, unusually heavy menstrual periods in women, or notice bruises appearing without remembering any injury. Small red spots on the skin called petechiae may appear, which are actually tiny bleeding points under the skin.[4]
Because the immune system is weakened by the lack of healthy white blood cells, infections become more frequent and may be harder to shake off. Fever or high temperature without an obvious cause is common. Some people experience shortness of breath, especially during physical activity, as their body struggles with reduced oxygen-carrying capacity.[4]
The disease can cause lymph nodes—small bean-shaped structures that help fight infection—to become swollen, particularly in the neck, armpits, or groin. The liver and spleen may enlarge, sometimes causing discomfort in the abdomen. Bone and joint pain can occur as the blast cells crowd the bone marrow. Unexplained weight loss and night sweats that soak through bedclothes are also possible symptoms.[4][7]
Patients with Ph+ ALL have an increased risk of the disease spreading to the central nervous system, which includes the brain and spinal cord. When this happens, additional symptoms may develop, such as headaches, seizures, problems with balance, blurred or double vision, nausea and vomiting, or facial muscle weakness or numbness.[1]
It’s important to understand that many of these symptoms can also be caused by other, less serious conditions such as viral infections like mononucleosis. However, because Ph+ ALL develops quickly, anyone experiencing these symptoms should contact their doctor promptly, especially if symptoms persist for more than two weeks.[7]
Prevention and Reducing Risk
Because Philadelphia positive acute lymphocytic leukaemia is caused by genetic changes that happen spontaneously inside cells, there is currently no proven way to prevent the disease entirely. Unlike some cancers where lifestyle changes can significantly reduce risk, the genetic mutations that lead to Ph+ ALL are largely random events that occur during a person’s life, or sometimes even before birth.[4]
However, there are some general steps people can take that may help reduce their overall cancer risk. Avoiding tobacco products is important, as tobacco use has been linked to the development of acute lymphocytic leukaemia in adults. Limiting exposure to radiation when possible may also be beneficial, though medical radiation for necessary treatments should never be avoided.[4]
For people with inherited genetic conditions that increase their risk of developing ALL, regular medical monitoring can help detect the disease early if it does develop. Early detection doesn’t prevent the disease, but it can lead to earlier treatment, which may improve outcomes.
Currently, there are no recommended screening tests for healthy people without symptoms or risk factors for Ph+ ALL. The disease is too rare in the general population to make widespread screening practical or beneficial. Instead, the focus remains on recognising symptoms early and seeking medical attention promptly when they appear.
Maintaining overall health through a balanced diet, regular physical activity, adequate sleep, and stress management supports the immune system and general wellbeing. While these practices don’t specifically prevent Ph+ ALL, they contribute to better health outcomes overall and may help the body better handle treatments if disease does develop.
How the Disease Changes the Body
Understanding what happens inside the body during Philadelphia positive acute lymphocytic leukaemia helps explain why the disease causes the symptoms it does. The process begins deep in the bone marrow, where all blood cells originate from cells called stem cells. Normally, these stem cells follow an orderly process of development, gradually maturing into the various types of blood cells the body needs.[3]
In healthy bone marrow, stem cells become either lymphoid stem cells or myeloid stem cells. Lymphoid stem cells develop into lymphocytes—the white blood cells that include B cells and T cells, both crucial for fighting infections. The development process involves several stages, with cells called lymphoblasts or blast cells serving as the immature version that eventually matures into fully functional lymphocytes.[6]
When Ph+ ALL develops, the BCR-ABL1 fusion gene disrupts this carefully controlled process. The abnormal gene produces excessive amounts of tyrosine kinase protein, which continuously signals the blast cells to multiply. These blast cells fail to mature properly and cannot perform the normal functions of healthy white blood cells. Instead of developing into infection-fighting lymphocytes, they remain stuck in an immature state.[3]
The abnormal blast cells multiply rapidly and relentlessly. As they accumulate in the bone marrow, they physically crowd out the space needed for normal blood cell production. This crowding effect is like a garden being overtaken by weeds—the weeds don’t just grow everywhere, they also prevent the desirable plants from having room to grow.[6]
The result is a shortage of all three main types of blood cells. Without enough red blood cells, the body cannot transport sufficient oxygen to tissues, leading to fatigue and shortness of breath. The lack of healthy white blood cells leaves the immune system weakened, making infections more frequent and harder to fight. The reduced number of platelets means blood doesn’t clot properly, resulting in easy bruising and bleeding.[6]
The blast cells don’t stay confined to the bone marrow. They spill out into the bloodstream and can travel throughout the body. They may collect in lymph nodes, causing them to swell. The liver and spleen can become enlarged as blast cells accumulate in these organs. In some cases, the cells infiltrate the brain and spinal cord, the protective covering around these structures called the meninges, or rarely, the testicles.[3][1]
The BCR-ABL1 protein essentially keeps the cellular growth machinery running at full speed without any brakes. In normal cells, growth signals turn on and off as needed, maintaining a careful balance. But in Ph+ ALL, the fusion protein created by the Philadelphia chromosome bypasses the normal control mechanisms, driving continuous, uncontrolled cell division.[3]
